|
|
|
|
HR0334 |
|
LRB094 12034 CSA 45174 r |
|
|
| 1 |
| HOUSE RESOLUTION
|
| 2 |
| WHEREAS, Ovarian cancer is the leading cause of death from |
| 3 |
| gynecologic cancers in the United States, and the fifth leading |
| 4 |
| cause of death among U.S. women; and
|
| 5 |
| WHEREAS, It is one of the most insidious types of cancer |
| 6 |
| affecting women of which has few signs or symptoms and is |
| 7 |
| difficult to detect; and
|
| 8 |
| WHEREAS, Ovarian cancer symptoms included bloating, |
| 9 |
| frequent urination, constipation, diarrhea, and fatigue; any |
| 10 |
| woman who experiences these symptoms for more than two to three |
| 11 |
| weeks should promptly have a thorough examination to determine |
| 12 |
| if ovarian cancer is present; and
|
| 13 |
| WHEREAS, Increased awareness of the symptoms and risk |
| 14 |
| factors of ovarian cancer will enhance chances of early |
| 15 |
| detection and survival from the disease; and
|
| 16 |
| WHEREAS, Prostate cancer is the most commonly diagnosed |
| 17 |
| non-skin cancer and the second leading cause of cancer-related |
| 18 |
| death among men; and
|
| 19 |
| WHEREAS, Prostate cancer has accounted for 15 percent of |
| 20 |
| the nation's cancer burden and 15 percent of male cancer |
| 21 |
| deaths; and
|
| 22 |
| WHEREAS, Research suggests that men can reduce their risk |
| 23 |
| of prostate cancer mortality if they follow recommended |
| 24 |
| prostate cancer screening guidelines; and
|
| 25 |
| WHEREAS, Increased awareness and use of early detection |
| 26 |
| practices by men is essential to controlling prostate cancer; |
| 27 |
| therefore, be it
|